Skip to main content
JNMA: Journal of the Nepal Medical Association logoLink to JNMA: Journal of the Nepal Medical Association
. 2020 Apr 30;58(224):223–229. doi: 10.31729/jnma.4841

Utilization of Pre-Anesthetic Medications for Major Surgical Procedures at a Tertiary Care Center: A Descriptive Cross-sectional Study

Rekha Shah 1,, Roshan Pradhan 2, Arbindra Shah 3
PMCID: PMC7580468  PMID: 32417858

ABSTRACT

Introduction:

Drug utilization research is an important tool to analyze the use of drugs with special emphasis on medical, social, and economic consequences in society. This study aims to find out the utilization of pre-anesthetic medications in a major surgical procedure.

Methods:

A descriptive cross-sectional study was conducted from 15th April - 15th August 2019 in the postoperative ward at Birat Medical College and Teaching Hospital. The convenience sampling method was used after ethical clearance from the Institutional Review Committee (IRC) of Birat Medical College and Teaching Hospital, Biratnagar, Nepal. About 400 patients were studied. The collected data were entered into a statistical package for social science version 20 for further calculations at 95% Confidence Interval.

Results:

Out of 400 patients, 215 (53.8%) of patients were underwent into different major surgeries. All patients received midazolam 2 mg except children (1 mg) and Pethidine 25 mg along with 0.2 mg glycopyrrolate 352 (88%), ondansetron 276 (69%) and others 58 (14.5%) as a preanesthetic agent. For general anesthesia propofol, 30 mg have been utilized followed by fentanyl 306 (76.5%) and others (halothane, isoflurane, etc) 115 (28.8%). In case of prophylactic drug were ceftriaxone 500 mg, 100 mg metoclopramide 387 (96.8%), dexamethasone 251 (62.8%), tramadol 237 (59.3%), 15 mg ketorolac 368 (92%), ranitidine 163 (40.8%), and pantoprazole 237 (59.3%).

Conclusions:

The most commonly administered pre-anesthetic drugs were midazolam, pethidine, glycopyrrolate, and ondansetron. The incidence of postoperative nausea and vomiting the patient within 24 hours after surgery was significantly very low.

Keywords: pre-anesthetic medications, surgical procedures, utilization

INTRODUCTION

Every year worldwide, approximately more than 310 million operations are performed,1 among them more than 200 million patients underwent major surgery.2 Pre-anesthetic medications are the drugs used before administration of an anesthetic agent.3 Introduction of such medication play the key role for improvement in the quality of health by counteracting stress and fear of surgery.4,5

About one-third of surgical patients received general anesthesia experience postoperative nausea and vomiting (PONV).6 After pain, PONV is the second most complaint in the post-operative ward. The patients who are not under PONV prophylaxis, the incidence rate of PONV was 70-80 %.7 To minimized the PONV several new drugs have been introduced but the incidence rate remains significantly high, ranging from 30%-35%.8 So to reduce it or to improve and for better prophylaxis combinations of drugs are used.914

As per our knowledge, this type of study has not been done yet in such settings so this study was designed to find out the utilization of pre-anesthetic medications in a major surgical procedure.

METHODS

This descriptive cross-sectional study was conducted from 15th April to 15th October 2019 at Birat Medical College and Teaching Hospital, Biratnagar, Nepal. Ethical clearance was taken from the Institutional Review Committee (IRC) of Birat Medical College and Teaching Hospital, Biratnagar, Nepal. Written permission was taken from each participant of the study. Inclusion criteria were those who gave consent or all patient of the postoperative ward who was willing to participate in the study and the participants of both sexes aged 6 years to 75 years. Exclusion criteria were those that do not give consent, age below 6 years and above 75 years. A semi-structured questionnaire and an observational checklist were used for data collection and face to face interviews were taken. The confidentiality and privacy of the study were maintained; the name of the individuals or the participating group was not disclosed after the study.

For the data collection, the pre-structured questionnaire was made by reviewing different literature and seeking opinions with the experts on the subject than appropriate modification was done. All patients aged from 6 to 70 years operated under general anesthesia given different pre-anesthetic medication before major surgery was noted in the questionnaire from the relevant patient file record. Data was collected two times 1st before operation from the patient's with present record file then after operation by face-to-face interview at the bedside along with record file in the post-operative ward. The confidentiality and privacy of the study were maintained; the name of the individuals or the participating group was not disclosed after the study. Here in this study, the side effect most commonly was seen was nausea and vomiting which is also called postoperative nausea and vomiting (PONV), therefore these have been noted.

Convenience sampling was done. The sample size was calculated as follow,

n= Z2×p ×q/e2= 3.84×0.5×0.5/(0.05)2= 384

where,

  • n = minimum sample size

  • p = prevalence, 50%

  • q = 1-p

  • e = margin of error, 5%

  • Z = 1.96 at 95 % CI

After taking a non-response rate of 4%, the total calculated sample for the study was taken to be 400 cases. Different biases present in the study such as selection bias and interviewer bias has been minimized as much possible. The collected data was entered in Microsoft excel and converted into SPSS (Statistical Package for Social Science) software package 20 version for statistical analysis. Data were analyzed using descriptive statistics for drug utilization. Point estimate at 95% CI was done along with frequency and proportion for binary data.

RESULTS

Laparoscopic appendectomy 124 (31%) becomes the highly done procedure followed by lab cholecystectomy 121 (30.3%) (Table 1). Midazolam 2 mg and pethidine 20 mg were utilized to all patients as a pre-anesthetic medication. The drugs administered as post-operative prophylaxis were ceftriaxone 500 mg to all patients followed by 100 mg metoclopramide.

Table 1. Utilization of medications in major surgery.

Characteristics n (%)
Procedure
 Lab appendectomy 124 (31.0)
 Laparoscopic cholecystectomy 121 (30.3)
 Cortical mastoidectomy 23 (5.8)
 Left tympanoplasty 41 (10.3)
 Tonsillectomy 35 (8.8)
 Excision of fibroadenoma 12 (3.0)
 Open cholecystectomy 21 (5.3)
 Others (reduction, perforation Peritonitis, etc) 23 (5.8)
Pre-anesthetic medication
Glycopyrrolate
 Yes 352 (88.0)
 No 48 (12.0)
Ondansetron
 Yes 276 (69.0)
 No 124 (31.0)
Others (buscopan, ketorolac, etc)
 Yes 58 (14.5)
 No 342 (85.5)
General Anesthetics
Fentanyl
 Yes 306 (76.5)
 No 94 (23.5)
Others (halothane, isoflurane, etc)
 Yes 115 (28.8)
 No 285 (71.3)
Post-operative drugs
Metoclopramide
 Yes 387 (96.8)
 No 13 (3.3)
Dexamethasone
 Yes 251 (62.8)
 No 149 (37.3)
Tramadol
 Yes 237 (59.3)
 No 163 (40.8)
Ketorolac
 Yes 368 (92.0)
 No 32 (8.0)
Ranitidine
 Yes 163 (40.8)
 No 237 (59.3)
Pantoprazole
 Yes 237 (59.3)
 No 162 (40.5)

Among the side effects nausea and vomiting being the most highly seen under post-operative drugs and pre-anesthetic medication in the post-operative ward (Table 2).

Table 2. Side effects observed under post-operative drugs and pre-anesthetic medication patients.

Characteristics n (%)
Side effects
Yes 119 (29.8)
No 281 (70.3)
Nausea
Yes 84 (21.0)
No 316 (79.0)
Vomiting
Yes 73 (18.3)
No
Others (pruritus, abdominal cramp, headache) 327 (81.8)
Yes 37 (9.3)
No 363 (90.8)
Total 400 (100)

Females were showed slightly higher side effects 75 (30.4%) as compared to males 44 (28.8%) but the difference was not significant. The relation between common Side effects (PONV) with Pre-anesthetic medication along with post-operative prophylaxis drugs was highly significant (Table 3).

Table 3. Association between age, gender, pre-anesthetic medication, and prophylaxis drugs with postoperative common side effects (PONV).

Characteristics Side effects within 24hrs after surgery Total n (%)
  Yes n (%) No n (%)  
Age
<18 years 6 (22.2) 21 (77.8) 27 (100)
18-24 years 25 (36.8) 43 (63.2) 68 (100)
25-39 years 63 (29.3) 152 (70.7) 215 (100)
40-59 years 21 (28.0) 54(72.0) 75 (100)
60 years 4 (26.7) 11(73.3) 15 (100)
Gender
Male 44 (28.8) 109 (71.2) 153 (100)
Female 75 (30.4) 172 (69.6) 247 (100)
Pre-anesthetic medication and prophylaxis drugs.
M, D, G, O* 15 (13.3) 98 (86.7) 113 (100)
M, D, G 11 (19.0) 47 (81.0) 58 (100)
D, G, O 39 (39.0) 61 (61.0) 100 (100)
M, G§ 13 (65.0) 7 (35.0) 20 (100)
M, G, O|| 23 (46.0) 27 (54.0) 50 (100)
M, O 12 (30.0) 28 (70.0) 40 (100)
M, D, O** 6 (31.6) 13 (68.4) 19 (100)
Total 119 (29.8) 281 (70.3) 400 (100)
M, D, G, O*

= metroclopramide, dexamethasone, glycopyrolate, ondansetrone

M, D, G†

= metroclopramide, dexamethasone, glycopyrolate,

D, G, O‡

= dexamethasone, glycopyrolate, odensetrone

M, G§

= metroclopramide, glycopyrolate

M, G, O||

= metroclopramide, glycopyrolate, odensetrone

M, O¶

= metroclopramide, odensetrone

M, D, O**

= metroclopramide, dexamethasone, odensetrone

The majority of the study population i.e. 215 (53.8%) belong to age groups of 25-39 years and minority i.e. 15 (3.8%) belong to the age group above 60 years. Almost 153 (38.3%) of the male were dominated by female 247 (61.8%) for the utilization of pre-anesthetic medication (Table 4).

Table 4. Distribution of study population by age and gender.

Characteristics n (%)
Age
<18 years 27 (6.8)
18-24 years 68 (17.0)
25-39 years 215 (53.8)
40-59 years 75 (18.8)
60 years 15 (3.8)
Gender
Male 153 (38.3)
Female 247 (61.8)
Total 400 (100)

DISCUSSION

Globally, 234.1 million major surgical procedures have been carried out every year.2 For major surgery, propofol from general anesthesia was mostly utilized in Di Filippo, et al,15,16 which was similar to our finding. Propofol was used for induction and maintenance purposes. This has a peculiar feature associated with earlier discharge from the post-anesthesia care unit.17,18 General anesthesia and surgery were responsible to develop postoperative complication like Postoperative Nausea and Vomiting (PONV)19,20 although there are multi-factorial reasons for PONV.2124 So to compensate for the above postoperative complication appropriate drugs in Preanesthetic medicine and prophylaxis drugs were utilized before and after surgery to reduce the adverse effect.

In our study identical premedication and standardized anesthetic technique25 (Balanced general anesthesia) was applied to all the patients who underwent major surgery. There were different surgical procedure estimated in this study, the major 3 operations which were highly done were laparoscopic (lap) appendectomy, 31.0% followed by laparoscopic (lap) cholecystectomy, 30.3%, Lf Tympanoplasty 10.3%, whereas, in the retrospective study conducted by Biondi A, et al.26 in 2016, 283 patients treated by laparoscopic appendectomy out of 593, Bajracharya A, et al.27 showed 346 laparoscopic cholecystectomies done at 2010 where the female was dominant on undergoing surgery. In our study, almost 61.8% of the female have dominated male patients 38.3%. Among 400 patients in our study, age group of 25-39 years has undergone surgery in the high category about 53.8% similarly a retrospective study conducted on 2019 by Gajjala R, et al. in which maximum surgeries were carried at the adult's age group 25-39 years, 49%.28 Santos ML, et al.29 did study on 2017, found similar age group of patients 18-59 years, 55.9%. This fact expresses that there is a progressive increase in surgery in younger age population. This implies the need for trained health professionals and institutions to care for this growing group of patients.

Among the pre-anesthetic medication, the benzodiazepine group of the drug was highly prescribed drugs.30 In our study Midazolam was commonly utilized drugs similar to finding Sheen MJ, et al.31 study whereas these findings differ from the studies of Patil A,32 Biswas P, et al.30 where the most commonly used anxiolytic was alprazolam. Here the glycopyrrolate 352 (88%) has been utilized which were more potent than atropine, used routinely as a pre-medication purpose and have less risk to the cardiovascular system, better control of oropharyngeal secretions during reversal stage8 when compared to Zeev N and Mirakur RK, et al. where atropine was the most commonly used.33,34 Another most important drugs utilized in our study as a pre-anesthetic medication was Ondansetron (69.0%) from antiemetic drugs. Establishment of 5-HT3 receptor antagonists approved by FDA brings drastic change in the prevention of postoperative nausea and vomiting.35

In this study there were a different type of major surgery has been done under general anesthesia where there was a high risk of incidence of PONV, especially observed in female gender similar to many studies done by Apfel, et al.36 Sinclair, et al.37 and Koivuranta, et al.38 found, to compensate the PONV different prophylactic drugs along with pre-anesthetic medication have been administered. Because the single drug was not 100% effective so the concept of combination antiemetic therapy was utilized which was first introduced in chemotherapy-induced vomiting.39 Several other studies in the literature also demonstrated that combined use of dexamethasone with other antiemetics decreases the incidence of PONV.40,41 Similar effectiveness was obtained in our study by the patients under prophylactic dexamethasone and metoclopramide along with administration of glycopyrrolate and ondansetron as pre-anesthetic medication showed very less side effect i.e. 15 (13.3%) out of 113 followed by metoclopramide, dexamethasone while glycopyrrolate has 11 (19.0%) out of 58 followed by metoclopramide, dexamethasone while ondansetron has 6 (31.6%) out of 19 respectively. This showed that prophylactic drugs along with pre-anesthetic medication were highly significant with side effects.

In our study population not only prophylaxis anti-emetic have been utilized but also other drugs such as pantoprazole, ranitidine, ketorolac, tramadol and antibiotic to compensate the side effect produce during and after surgery. Pantoprazole was the most highly utilized drugs followed by ranitidine in our study; the finding was similar to a study by Biswas P, et al.30 done in 2014. In a meta-analysis by Clark K, et al. found the opposite result where H2 blockers were effective drug compared to proton pump inhibitor (PPI) in reducing the gastric volume and pH.42

Surgery is one of the painful procedures so to reduce, strong analgesic was utilized here such as ketorolac 368 (92.0%), tramadol 237 (59.3%) and short-acting opioid, fentanyl 306 (76.5%). Fentanyl being the strong pain reliever but decrease the hemodynamic response to tracheal intubation in high dose.43 For these reasons, non-opioid agents to opioid-based regimens were added. Ketorolac is a common adjunct in major surgical protocols.44 According to the plethora of guidelines and study reporting the use of third-generation cephalosporins, ceftriaxone for surgical prophylaxis which was also followed in our study.45

In this study only the most commonly observed side effect that is nausea and vomiting within 24 hours of operation have been recorded but late PONV, as well as another individual side effect, was not able to measure. We were not able to record all the PONV promptly within 24 hours after surgery, which has undergone major surgery. Therefore, there may be a chance of observational bias done by nursing staff during recording side effects.

CONCLUSIONS

The most commonly administered Pre-anesthetic drugs are midazolam followed by pethidine was highly utilized pre-anesthetic medication. The other Preanesthetic medication were less utilized compared to above were glycopyrrolate, ondansetron, and others (buscopan, ketorolac, etc). The incidence of PONV to the patient within 24 hours after surgery was significantly very low to the patients who received glycopyrrolate and ondansetron as Preanesthetic medication along with metoclopramide and dexamethasone (MDGO) as prophylaxis drugs compared to another group of drugs in postoperative ward.

ACKNOWLEDGEMENTS

We would like to thanks all the Nursing staff of Birat medical college and Teaching hospital for his co-operation during data collection. Special thanks go to Dr. Ram Bilakshan Shah and Dr. Tara Kafle for guiding in data analysis. We would like to thanks Dr. Surya B. Parajuli for the review of this manuscript during protocol summation.

Conflict of Interest

None.

REFERENCES

  • 1.Wiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. The Lancet. 2015 Apr 27;385:S11. doi: 10.1016/S0140-6736(15)60806-6. [DOI] [PubMed] [Google Scholar]
  • 2.Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, et al. An estimation of the global volume of surgery: a modeling strategy based on available data. The Lancet. 2008;372(9633):139–44. doi: 10.1016/S0140-6736(08)60878-8. Epub 2008 Jun 24. [DOI] [PubMed] [Google Scholar]
  • 3.Peter J. Oxford Textbook of Surgery. 4th. Morris, William C: Oxford University Press; 2004. [Google Scholar]
  • 4.Kain ZN, Mayes LC, Bell C, Weisman S, Hofstadter MB, Rimar S. Premedication in the United States: a status report. Anesth Analg. 1997;84(2):427–32. doi: 10.1097/00000539-199702000-00035. [DOI] [PubMed] [Google Scholar]
  • 5.Roizen MF, Foss JF, Fischer SP. In: Preoperative evaluation. 5th. Miller RD, editor. Anesthesia. Philadelphia: Churchill-Livingstone; 2000. pp. 824–83p. [Google Scholar]
  • 6.Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350(24):2441–51. doi: 10.1056/NEJMoa032196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bhattacharjee DP, Dawn S, Nayak S, Rov PR, Acharya A, Dev R. A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):480–3. [PMC free article] [PubMed] [Google Scholar]
  • 8.Roberts SM, Bezinover DS, Janicki PK. Reappraisal of the role of dolasetron in the prevention and treatment of nausea and vomiting associated with surgery or chemotherapy. Cancer Manag Res. 2012;4:67–73. doi: 10.2147/CMAR.S15545. Epub 2012 Feb 24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Habib AS, Gan TJ. Combination antiemetic: what is the evidence? Int Anesthesiol Clin. 2003 Fall;41(4):119–44. doi: 10.1097/00004311-200341040-00010. [DOI] [PubMed] [Google Scholar]
  • 10.Wong HY, Fragen RJ, Dunn K. Dose-finding study of intramuscular midazolam pre-anesthetic medication in the elderly. Anesthesiology. 1991 Apr;74(4):675–9. doi: 10.1097/00000542-199104000-00010. [DOI] [PubMed] [Google Scholar]
  • 11.Kongsrud F, Sponheim S. A comparison of atropine and glycopyrrolate in anaesthetic practice. Acta Anaesthesiol Scand. 1982 Dec;26(6):620–5. doi: 10.1111/j.1399-6576.1982.tb01827.x. [DOI] [PubMed] [Google Scholar]
  • 12.Rautakorpi P, Manner T, Kanto J. A survey of current usage of anticholinergic drugs in pediatric anesthesia in Finland. Acta Anaesthesiol Scand. 1999 Oct;43(10):1057–9. doi: 10.1034/j.1399-6576.1999.431015.x. [DOI] [PubMed] [Google Scholar]
  • 13.Jain R, Sharma R. A comparative study of effects of glycopyrrolate and ondansetron on nausea and vomiting in cesarean section under spinal anesthesia. Anesth Essays Res. 2015;9:348–52. doi: 10.4103/0259-1162.159725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ai Q, Wang Y, Wu S, Qin Z, Wang G, Zhang J, et al. Pentazocine pretreatment suppresses fentanyl-induced cough. Pharmacol Res. 2010 Jul-Aug;62(4):747–50. doi: 10.1016/S1734-1140(10)70333-9. [DOI] [PubMed] [Google Scholar]
  • 15.Di Filippo A, Giunta F, Paolocchi A. Anesthesia in Italy in 2000: sciences and working practice. Minerva Anestesiol. 2002 Oct;68(10):751–63. [PubMed] [Google Scholar]
  • 16.Suri Y. Evaluation of midazolam and diazepam for preoperative sedation. Med J Armed Forces India. 2000 Oct;56(4):287–92. doi: 10.1016/S0377-1237(17)30209-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kulkarni M, Patil A. A cross-sectional pharmaco-epide-miological study of the utilization pattern of pre-anesthetic medications in major surgical procedures in a tertiary care hospital. Cureus. 2017 Jun;9(6):e1344. doi: 10.7759/cureus.1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tang J, Chen L, White PF, Watcha MF, Wender RH, Nurse R, et al. Recovery profile, costs, and patient satisfaction with propofol and sevoflurane for fast-track office-based anesthesia. Anesthesiology. 1999 Jul;91(1):253–61. doi: 10.1097/00000542-199907000-00034. [DOI] [PubMed] [Google Scholar]
  • 19.Apfel CC, Kranke P, Katz MH, Goepfert C, Papenfuss T, Rauch S, et al. Volatile anesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth. 2002 May;88(5):659–68. doi: 10.1093/bja/88.5.659. [DOI] [PubMed] [Google Scholar]
  • 20.Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anesthesia? Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):485–500. doi: 10.1016/j.bpa.2005.03.001. [DOI] [PubMed] [Google Scholar]
  • 21.Kenny GN. Risk factors for postoperative nausea and vomiting. Anesthesia. 1994 Jan;49(Suppl:6-10) doi: 10.1111/j.1365-2044.1994.tb03576.x. [DOI] [PubMed] [Google Scholar]
  • 22.Andrews PL. Physiology of nausea and vomiting. Br J Anesth. 1992;69(7 Suppl 1):2–19S. doi: 10.1093/bja/69.supplement_1.2S. [DOI] [PubMed] [Google Scholar]
  • 23.Lerman J. Surgical and patient factors involved in postoperative nausea and vomiting. Br J Anaesth. 1992;69(7 Suppl 1):24–32S. doi: 10.1093/bja/69.supplement_1.24S. [DOI] [PubMed] [Google Scholar]
  • 24.Shafer A, White PF, Urquhart ML, Doze VA. Outpatient premedication: use of midazolam and opioid analgesics. Anesthesiology. 1989 Oct;71(4):495–501. doi: 10.1097/00000542-198910000-00004. [DOI] [PubMed] [Google Scholar]
  • 25.Biondi A, Di Stefano C, Ferrara F, Bellia A, Vacante M, Piazza L. Laparoscopic versus open appendectomy: a retrospective cohort study assessing outcomes and cost-effectiveness. World J Emerg Surg. 2016 Aug 30;11(1):44. doi: 10.1186/s13017-016-0102-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bajracharya A, Adhikary S, Agrawal CS. Laparoscopic cholecystectomy: an experience of university hospital in eastern Nepal. Health Renaissance. 2012;10(1):46–8. doi: 10.3126/hren.v10i1.6007. [DOI] [Google Scholar]
  • 27.Gajjala LR, Adepu M, Dasari A, Prusty KB. Drug utilization review of anesthetics in the surgery department of tertiary care hospitals of Warangal Region. Indian Journal of Pharmacy Practice. 2019 Jan;12(1):15–20. doi: 10.5530/ijopp.12.1.4. [DOI] [Google Scholar]
  • 28.Santos ML, Novaes CO, Iglesias AC. [Epidemiological profile of patients seen in the pre-anesthetic assessment clinic of a university hospital] Rev Bras Anestesiol. 2017 Sep-Oct;67(5):457–67. doi: 10.1016/j.bjane.2017.04.006. [DOI] [PubMed] [Google Scholar]
  • 29.Biswas P, Niveditha, Shivamurthy MC. A study to evaluate the pattern of pre-anaesthetic medication in various surgical specialties in a tertiary care hospital. Int J Pharm Sci Res. 2014;5(6):2441–6. [Google Scholar]
  • 30.Sheen MJ, Chang FL, Ho ST. Anesthetic premedication: new horizons of an old practice. Acta Anaesthesiol Taiwan. 2014 Sep;52(3):134–42. doi: 10.1016/j.aat.2014.08.001. [DOI] [PubMed] [Google Scholar]
  • 31.Patil A, Kulkarni M. Pre-anesthetic medications in patients undergoing exploratory laparotomy: results of a cross-sectional study. Asian Journal of Pharmaceuticals and Clinical Research. 2018 Mar;11(3):277–9. doi: 10.22159/ajpcr.2018.v11i3.23229. [DOI] [Google Scholar]
  • 32.Mirakhur RK. Preanaesthetic medication: a survey of current usage. J R Soc Med. 1991 Aug;84(8):481–3. doi: 10.1177/014107689108400811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kain ZN, Mayes LC, Bell C, et al. Premedication in the United States: a status report. Anesth Analg. 1997 Feb;84(2):427–32. doi: 10.1097/00000539-199702000-00035. [DOI] [PubMed] [Google Scholar]
  • 34.Ahmed YM, Messiha BA, Abo-Saif AA. Granisetron and carvedilol can protect experimental rat's against adjuvant-induced arthritis. Immunopharmacol Immunotoxicol. 2017 Apr;39(2):97–104. doi: 10.1080/08923973.2017.1286502. [DOI] [PubMed] [Google Scholar]
  • 35.Apfel CC, Greim CA, Haubitz I, Goepfert C, Usadel J, Sefrin P, et al. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand. 1998 May;42(5):495–501. doi: 10.1111/j.1399-6576.1998.tb05157.x. [DOI] [PubMed] [Google Scholar]
  • 36.Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology. 1999 Jul;91(1):109–18. doi: 10.1097/00000542-199907000-00018. [DOI] [PubMed] [Google Scholar]
  • 37.Koivuranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anesthesia. 1997 May;52(5):443–9. doi: 10.1111/j.1365-2044.1997.117-az0113.x. [DOI] [PubMed] [Google Scholar]
  • 38.Palazzo MGA, Strunin L. Anaesthesia, and emesis. I: etiology. Can Anaesth Soc J. 1984 Mar;31(2):178–87. doi: 10.1007/BF03015257. [DOI] [PubMed] [Google Scholar]
  • 39.De Oliveira GS, Jr, Castro-Alves LJ, Ahmad S. Dexamethasone to prevent postoperative nausea and vomiting: an meta-analysis of randomized controlled trials. Anesth Analg. 2013 Jan;116(1):58–74. doi: 10.1213/ANE.0b013e31826f0a0a. [DOI] [PubMed] [Google Scholar]
  • 40.Song JW, Park EY, Lee JG, Park YS, Kang BC, Shim YH. The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. Anesthesia. 2011 Apr;66(4):263–7. doi: 10.1111/j.1365-2044.2011.06648.x. [DOI] [PubMed] [Google Scholar]
  • 41.Clark K, Lam LT, Gibson S, Currow D. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomized control trials. Anesthesia. 2009 Jun;64(6):652–7. doi: 10.1111/j.1365-2044.2008.05861.x. [DOI] [PubMed] [Google Scholar]
  • 42.Lim H, Doo AR, Son JS, Kim JW, Lee KJ, Kim DC, et al. Effects of intraoperative single bolus fentanyl administration and remifentanil infusion on postoperative nausea and vomiting. Korean J Anesthesiol. 2016 Feb;69(1):51–6. doi: 10.4097/kjae.2016.69.1.51. Epub 2016 Jan 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.De Oliveira GS, Jr, Agarwal D, Benzon HT. Perioperative single-dose ketorolac to prevent postoperative pain: a meta-analysis of randomized trials. Anesth Analg. 2012;114(2):424–33. doi: 10.1213/ANE.0b013e3182334d68. Epub 2011 Sep 29. [DOI] [PubMed] [Google Scholar]
  • 44.Khan AK, Mirshad RV, Mohammed RR, Banu G. A study on the usage pattern of antimicrobial agents for the prevention of surgical site infections (SSIs) in a tertiary care teaching hospital. J Clin Diagn Res. 2013 Apr;7(4):671–4. doi: 10.7860/JCDR/2013/5323.2878. Epub 2013 Feb 27. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JNMA: Journal of the Nepal Medical Association are provided here courtesy of Nepal Medical Association

RESOURCES